BioCentury
ARTICLE | Clinical News

Surepost repaglinide regulatory update

March 11, 2013 7:00 AM UTC

Dainippon said Japan's Ministry of Health, Labor and Welfare (MHLW) approved an expanded label for Type II diabetes drug Surepost repaglinide tablets to include combination therapy with thiazolidinedi...